On October 22, 2020 GO2 Foundation for Lung Cancer reported it will celebrate Genentech with the "Simply the Best Award" at its XV Virtual Annual Simply the Best Gala on November 14, 2020 at 6:30 pm PT (Press release, Bonnie J Addario Lung Cancer Foundation, OCT 22, 2020, View Source [SID1234568828]). Genentech will be honored for its continued dedication to research and development of new lung cancer treatments.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

"Lung cancer is a major area of focus and investment for Genentech, and we are committed to developing new approaches, medicines and tests that can help people with this deadly disease," said Alan Sandler, Global Head of Product Development Oncology. "We are honored to be recognized by the GO2 Foundation for Lung Cancer as we work toward more effective treatment options for every person diagnosed with lung cancer."

Genentech currently has five approved medicines to treat certain kinds of lung cancer and more than 10 medicines being developed to target the most common genetic drivers of lung cancer or to boost the immune system to combat the disease.

As the understanding and treatment of lung cancer continues to advance, so do the number of people diagnosed with the disease. Each year, nearly 225,000 Americans receive a lung cancer diagnosis and more than 160,000 will die of the disease. Eighty percent of those recently diagnosed never smoked, or quit more than a decade ago.

"While significant challenges of lung cancer remain, thanks to the many pioneers in research, discovery and treatment, like Genentech and our other awardees, we are moving closer each day to making lung cancer a manageable chronic disease," said Bonnie J. Addario, 15-year lung cancer survivor, co-founder and chair of GO2 Foundation.

Due to distancing protocols during the pandemic, the Simply the Best Gala, GO2’s largest annual fundraising event, will be held virtually this year.

"While we never imagined we wouldn’t all be together in person for our 15th Annual Simply the Best Gala, we look forward to joining together virtually to celebrate the groundbreaking achievements of the cancer researchers and treatment developers who support our efforts to advance lung cancer research and patient care," said Laurie Fenton Ambrose, co-founder of the GO2 Foundation for Lung Cancer.